60717-45-5 Usage
General Description
N-Methyl-1-(phenylmethyl)-3-piperidinamine is a chemical compound with the molecular formula C16H24N2. It is a tertiary amine with a piperidine ring and a phenylmethyl group attached to the nitrogen atom. N-Methyl-1-(phenylmethyl)-3-piperidinamine is commonly used as a building block in organic synthesis and pharmaceutical research. It has also been studied for its potential therapeutic applications, particularly in the treatment of pain and central nervous system disorders. N-Methyl-1-(phenylmethyl)-3-piperidinamine is a white to off-white crystalline powder that is typically handled and stored with caution due to its potential hazards and toxicological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 60717-45-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,7,1 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 60717-45:
(7*6)+(6*0)+(5*7)+(4*1)+(3*7)+(2*4)+(1*5)=115
115 % 10 = 5
So 60717-45-5 is a valid CAS Registry Number.
60717-45-5Relevant articles and documents
For the prevention and treatment of various autoimmune diseases of the new compound
-
Paragraph 0139; 0140; 0141, (2018/04/20)
Disclosed is an isoxazole derivative that inhibits the activity of the Janus kinases (JAKs), the structure thereof as presented in formula I, formula II, formula IX, and formula XI. The substituent groups in the formulas are described in the description. Also disclosed are the pharmaceutical composition of the compound and a related use in medicine preparation.
Monocyclic Analogues of the μ-Opioid Agonist 3,8-Diazabicyclooctanes: Synthesis, Modeling, and Activity
Barlocco, Daniela,Villa, Stefania,Fratta, Walter,Fadda, Paola,Colombo, Diego,Toma, Lucio
, p. 11547 - 11556 (2007/10/02)
Several monocyclic derivatives structurally related to the μ-opioid agonist 3-cinnamyl-8-propionyl-3,8-diazabicyclooctane have been synthesized and tested in binding studies using the μ-selective 3H-DAMGO as ligand.Modeling studies have been performed on the same compounds in order to explain the observed lack of affinity towards μ-opioid receptors.
